These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 24382629)
21. Pathological Endogenous α-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. Kaji S; Maki T; Kinoshita H; Uemura N; Ayaki T; Kawamoto Y; Furuta T; Urushitani M; Hasegawa M; Kinoshita Y; Ono Y; Mao X; Quach TH; Iwai K; Dawson VL; Dawson TM; Takahashi R Stem Cell Reports; 2018 Feb; 10(2):356-365. PubMed ID: 29337114 [TBL] [Abstract][Full Text] [Related]
22. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Stefanova N; Kaufmann WA; Humpel C; Poewe W; Wenning GK Acta Neuropathol; 2012 Jul; 124(1):51-65. PubMed ID: 22491959 [TBL] [Abstract][Full Text] [Related]
23. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615 [TBL] [Abstract][Full Text] [Related]
24. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. Suzuki Y; Jin C; Yazawa I Am J Pathol; 2014 Mar; 184(3):790-9. PubMed ID: 24405769 [TBL] [Abstract][Full Text] [Related]
26. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499 [TBL] [Abstract][Full Text] [Related]
27. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential. Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813 [TBL] [Abstract][Full Text] [Related]
30. Oligodendrocyte maturation is inhibited by bone morphogenetic protein. See J; Zhang X; Eraydin N; Mun SB; Mamontov P; Golden JA; Grinspan JB Mol Cell Neurosci; 2004 Aug; 26(4):481-92. PubMed ID: 15276151 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease. Decressac M; Mattsson B; Björklund A Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547 [TBL] [Abstract][Full Text] [Related]
32. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942 [TBL] [Abstract][Full Text] [Related]
34. Activation of FXR pathway does not alter glial cell function. Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity. Kuzdas-Wood D; Fellner L; Premstaller M; Borm C; Bloem B; Kirik D; Wenning GK; Stefanova N BMC Neurosci; 2015 Dec; 16():86. PubMed ID: 26627686 [TBL] [Abstract][Full Text] [Related]
36. Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy. Nakayama K; Suzuki Y; Yazawa I Biochem Biophys Res Commun; 2012 Jan; 417(4):1170-5. PubMed ID: 22227187 [TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein overexpression in oligodendrocytic cells results in impaired adhesion to fibronectin and cell death. Tsuboi K; Grzesiak JJ; Bouvet M; Hashimoto M; Masliah E; Shults CW Mol Cell Neurosci; 2005 Jun; 29(2):259-68. PubMed ID: 15911350 [TBL] [Abstract][Full Text] [Related]
38. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. Paintlia MK; Paintlia AS; Barbosa E; Singh I; Singh AK J Neurosci Res; 2004 Nov; 78(3):347-61. PubMed ID: 15389835 [TBL] [Abstract][Full Text] [Related]
39. The neuropathology of multiple system atrophy and its therapeutic implications. Valera E; Masliah E Auton Neurosci; 2018 May; 211():1-6. PubMed ID: 29169744 [TBL] [Abstract][Full Text] [Related]
40. Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models. Mavroeidi P; Arvanitaki F; Vetsi M; Becker S; Vlachakis D; Jensen PH; Stefanis L; Xilouri M Autophagy; 2022 Sep; 18(9):2104-2133. PubMed ID: 35000546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]